265 related articles for article (PubMed ID: 2150592)
1. Pharmacology and therapeutic effects of nicorandil.
Kinoshita M; Sakai K
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
[TBL] [Abstract][Full Text] [Related]
2. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Frampton J; Buckley MM; Fitton A
Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
[TBL] [Abstract][Full Text] [Related]
3. Nicorandil: animal pharmacology.
Sakai K
Am J Cardiol; 1989 Jun; 63(21):2J-10J. PubMed ID: 2525321
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
Krumenacker M; Roland E
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
[TBL] [Abstract][Full Text] [Related]
5. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
Araki H; Hayata N; Matsuguchi T; Nakamura M
Clin Ther; 1987; 9(2):174-82. PubMed ID: 2952276
[TBL] [Abstract][Full Text] [Related]
6. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
[TBL] [Abstract][Full Text] [Related]
7. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
Goldschmidt M; Landzberg BR; Frishman WH
J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
[TBL] [Abstract][Full Text] [Related]
9. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.
Taira N
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S1-9. PubMed ID: 2447414
[TBL] [Abstract][Full Text] [Related]
10. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
Camm AJ; Maltz MB
Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
[TBL] [Abstract][Full Text] [Related]
12. Acute hemodynamic effects of nicorandil in coronary artery disease.
Treese N; Erbel R; Meyer J
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S52-6. PubMed ID: 1282176
[TBL] [Abstract][Full Text] [Related]
13. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
14. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
[TBL] [Abstract][Full Text] [Related]
16. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
Hayata N; Araki H; Nakamura M
Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
[TBL] [Abstract][Full Text] [Related]
17. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.
Kishida H; Hata N; Kusama Y; Iwahara S; Sasaki Y; Mori N; Yasutake M; Koumi S; Takayama M; Munakata K
Jpn Heart J; 1990 Mar; 31(2):135-43. PubMed ID: 2141366
[TBL] [Abstract][Full Text] [Related]
18. [Effects of nicorandil on coronary collateral circulation depend on the donor arteries].
Umezawa S; Ogawara S; Okamoto Y; Igawa M; Aonuma K; Inada M; Korenaga M; Hiroe M; Marumo F
J Cardiol; 1996 Nov; 28(5):257-66. PubMed ID: 8953399
[TBL] [Abstract][Full Text] [Related]
19. Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris.
Hiasa Y; Hamai K; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y
Tokushima J Exp Med; 1989 Dec; 36(3-4):65-70. PubMed ID: 2534651
[TBL] [Abstract][Full Text] [Related]
20. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.
Di Somma S; Liguori V; Petitto M; Carotenuto A; Bokor D; de Divitiis O; de Divitiis M
Cardiovasc Drugs Ther; 1993 Feb; 7(1):119-23. PubMed ID: 8485067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
